Loading viewer...
investor_presentation
Format: PDF investor_presentation
Moderna presented its digital investor event on November 8, 2023, discussing the potential of its mRNA platform and applications of artificial intelligence for scaling. The presentation outlined plans to launch up to 15 products within the next 5 years and advance individualized neoantigen therapy for cancer treatment.
conference
25 Pages
investor_presentation
29 Pages
Illumina
Applied Industrial Technologies Q4 2023 Earnings & FY24 Outlook
investor_presentationinvestor_presentation
19 Pages
Applied Industrial Technologies
investor_presentation
UTStarcom Holdings